The SCAC is currently undergoing restructuring and has paused updates to the Clearinghouse website. As a courtesy to our users, the New Filings email will continue to be provided by the Stanford Securities Litigation Analytics project during this period.
Aimmune Investors' $27.5M Deal in Nestle Suit Gets Final OK
Emilie Ruscoe, Law360 - Securities, July 21, 2025
Excerpt:
Investors in biopharmaceutical company Aimmune Therapeutics Inc. have gotten final approval for their $27.5 million deal resolving claims the company was falsely undervalued before its merger with Nestlé Health Science SA. [...]
